Cargando…

Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage

New cell and tissue sources are needed for the regenerative treatment of articular cartilage damage. Human induced pluripotent stem cells (hiPSCs) are an abundant cell source due to their self-renewal capacity. Hyaline cartilage tissue particles derived from hiPSCs (hiPS-Carts), 1–3 mm in diameter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xike, Yamashita, Akihiro, Morioka, Miho, Senba, Toshika, Kamatani, Takashi, Watanabe, Akira, Kosai, Azuma, Tsumaki, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450455/
https://www.ncbi.nlm.nih.gov/pubmed/30129877
http://dx.doi.org/10.1089/ten.tea.2018.0133
_version_ 1783409026201026560
author Chen, Xike
Yamashita, Akihiro
Morioka, Miho
Senba, Toshika
Kamatani, Takashi
Watanabe, Akira
Kosai, Azuma
Tsumaki, Noriyuki
author_facet Chen, Xike
Yamashita, Akihiro
Morioka, Miho
Senba, Toshika
Kamatani, Takashi
Watanabe, Akira
Kosai, Azuma
Tsumaki, Noriyuki
author_sort Chen, Xike
collection PubMed
description New cell and tissue sources are needed for the regenerative treatment of articular cartilage damage. Human induced pluripotent stem cells (hiPSCs) are an abundant cell source due to their self-renewal capacity. Hyaline cartilage tissue particles derived from hiPSCs (hiPS-Carts), 1–3 mm in diameter, are one candidate source that can be used for transplantation. When transplanted to fill the defects of articular cartilage, hiPS-Carts form a repair tissue by integrating with each other and with adjacent host tissue. In this study, we analyzed the integration capacity using an in vitro model and found that hiPS-Carts spontaneously integrate with each other in vitro. hiPS-Carts consist of cartilage at the center and perichondrium-like membrane that wraps around the cartilage. The integration started at the perichondrium-like membrane at around 1 week. Then, the integration progressed to the cartilage within 4–8 weeks. RNA sequencing analysis identified a higher expression of FGF18 in the perichondrium-like membrane in hiPS-Carts compared with the central cartilage. The addition of FGF18 to the model accelerated the integration of hiPS-Carts, whereas the addition of a FGFR inhibitor inhibited it. These results suggest that FGF18 secreted from the perichondrium-like membrane plays a role in the integration of hiPS-Carts. Understanding the integration mechanism of hiPS-Carts is expected to contribute to the realization of regenerative treatment for patients with articular cartilage damage. IMPACT STATEMENT: Cartilage particles derived from human induced pluripotent stem cells (hiPS-Carts) are one candidate source for transplants for treatment of articular cartilage damage. This study shows that hiPS-Carts integrate with each other in an in vitro model and analyzed the course of the integration. The integration starts at the perichondrium-like membrane at around 1 week and then progresses to the central cartilage within 4–8 weeks. The results indicate that FGF18 secreted from the perichondrium-like membrane accelerates the initial step of integration. The findings contribute to understanding how hiPS-Carts form repair tissue and provide clue to accelerate healing after transplantation.
format Online
Article
Text
id pubmed-6450455
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-64504552019-04-08 Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage Chen, Xike Yamashita, Akihiro Morioka, Miho Senba, Toshika Kamatani, Takashi Watanabe, Akira Kosai, Azuma Tsumaki, Noriyuki Tissue Eng Part A Original Articles New cell and tissue sources are needed for the regenerative treatment of articular cartilage damage. Human induced pluripotent stem cells (hiPSCs) are an abundant cell source due to their self-renewal capacity. Hyaline cartilage tissue particles derived from hiPSCs (hiPS-Carts), 1–3 mm in diameter, are one candidate source that can be used for transplantation. When transplanted to fill the defects of articular cartilage, hiPS-Carts form a repair tissue by integrating with each other and with adjacent host tissue. In this study, we analyzed the integration capacity using an in vitro model and found that hiPS-Carts spontaneously integrate with each other in vitro. hiPS-Carts consist of cartilage at the center and perichondrium-like membrane that wraps around the cartilage. The integration started at the perichondrium-like membrane at around 1 week. Then, the integration progressed to the cartilage within 4–8 weeks. RNA sequencing analysis identified a higher expression of FGF18 in the perichondrium-like membrane in hiPS-Carts compared with the central cartilage. The addition of FGF18 to the model accelerated the integration of hiPS-Carts, whereas the addition of a FGFR inhibitor inhibited it. These results suggest that FGF18 secreted from the perichondrium-like membrane plays a role in the integration of hiPS-Carts. Understanding the integration mechanism of hiPS-Carts is expected to contribute to the realization of regenerative treatment for patients with articular cartilage damage. IMPACT STATEMENT: Cartilage particles derived from human induced pluripotent stem cells (hiPS-Carts) are one candidate source for transplants for treatment of articular cartilage damage. This study shows that hiPS-Carts integrate with each other in an in vitro model and analyzed the course of the integration. The integration starts at the perichondrium-like membrane at around 1 week and then progresses to the central cartilage within 4–8 weeks. The results indicate that FGF18 secreted from the perichondrium-like membrane accelerates the initial step of integration. The findings contribute to understanding how hiPS-Carts form repair tissue and provide clue to accelerate healing after transplantation. Mary Ann Liebert, Inc., publishers 2019-03-01 2019-03-14 /pmc/articles/PMC6450455/ /pubmed/30129877 http://dx.doi.org/10.1089/ten.tea.2018.0133 Text en © Xike Chen et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited.
spellingShingle Original Articles
Chen, Xike
Yamashita, Akihiro
Morioka, Miho
Senba, Toshika
Kamatani, Takashi
Watanabe, Akira
Kosai, Azuma
Tsumaki, Noriyuki
Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
title Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
title_full Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
title_fullStr Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
title_full_unstemmed Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
title_short Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
title_sort integration capacity of human induced pluripotent stem cell-derived cartilage
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450455/
https://www.ncbi.nlm.nih.gov/pubmed/30129877
http://dx.doi.org/10.1089/ten.tea.2018.0133
work_keys_str_mv AT chenxike integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT yamashitaakihiro integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT moriokamiho integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT senbatoshika integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT kamatanitakashi integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT watanabeakira integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT kosaiazuma integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage
AT tsumakinoriyuki integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage